Recently, a novel molecular subtype model of SCLC defined by four transcription factors (ASCL1, NEUROD1, POU2F3, and YAP1) was proposed8, 9 and these subtypes were reported to have distinct therapeutic vulnerabilities.8, 10, 11. Here, ASCL1 is linked to small cell lung carcinoma.